Dopamine Uptake Inhibitors
"Dopamine Uptake Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.
| Descriptor ID |
D018765
|
| MeSH Number(s) |
D27.505.519.562.437.220 D27.505.519.625.150.800 D27.505.519.625.600.220 D27.505.696.577.150.800 D27.505.696.577.600.220
|
| Concept/Terms |
Dopamine Uptake Inhibitors- Dopamine Uptake Inhibitors
- Reuptake Inhibitors, Dopamine
- Inhibitors, Dopamine Uptake
- Uptake Inhibitors, Dopamine
- Inhibitors, Dopamine Reuptake
- Dopamine Reuptake Inhibitors
|
Below are MeSH descriptors whose meaning is more general than "Dopamine Uptake Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Dopamine Uptake Inhibitors".
This graph shows the total number of publications written about "Dopamine Uptake Inhibitors" by people in this website by year, and whether "Dopamine Uptake Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 2 | 1 | 3 |
| 1999 | 2 | 1 | 3 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 6 | 0 | 6 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 3 | 4 | 7 |
| 2007 | 7 | 3 | 10 |
| 2008 | 2 | 5 | 7 |
| 2009 | 1 | 2 | 3 |
| 2010 | 5 | 0 | 5 |
| 2011 | 4 | 3 | 7 |
| 2012 | 6 | 3 | 9 |
| 2013 | 5 | 4 | 9 |
| 2014 | 4 | 2 | 6 |
| 2015 | 2 | 2 | 4 |
| 2016 | 3 | 1 | 4 |
| 2017 | 5 | 6 | 11 |
| 2018 | 4 | 2 | 6 |
| 2019 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine Uptake Inhibitors" by people in Profiles.
-
Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation. J Neuroimmune Pharmacol. 2020 06; 15(2):209-223.
-
Lipidomic changes in the rat hippocampus following cocaine conditioning, extinction, and reinstatement of drug-seeking. Brain Behav. 2019 12; 9(12):e01451.
-
The activity-regulated cytoskeleton-associated protein, Arc/Arg3.1, influences mouse cocaine self-administration. Pharmacol Biochem Behav. 2020 01; 188:172818.
-
Transient synaptic potentiation in nucleus accumbens shell during refraining from cocaine seeking. Addict Biol. 2020 05; 25(3):e12759.
-
Biphasic effect of abstinence duration following cocaine self-administration on spine morphology and plasticity-related proteins in prelimbic cortical neurons projecting to the nucleus accumbens core. Brain Struct Funct. 2019 Mar; 224(2):741-758.
-
ARC and BDNF expression after cocaine self-administration or cue-induced reinstatement of cocaine seeking in adolescent and adult male rats. Addict Biol. 2018 11; 23(6):1233-1241.
-
Regionally Specific Effects of Oxytocin on Reinstatement of Cocaine Seeking in Male and Female Rats. Int J Neuropsychopharmacol. 2018 07 01; 21(7):677-686.
-
Accumbens brain-derived neurotrophic factor (BDNF) transmission inhibits cocaine seeking. Addict Biol. 2019 09; 24(5):860-873.
-
Heroin seeking becomes dependent on dorsal striatal dopaminergic mechanisms and can be decreased by N-acetylcysteine. Eur J Neurosci. 2019 08; 50(3):2036-2044.
-
Drug-sensitive Reward in Crayfish: Exploring the Neural Basis of Addiction with Automated Learning Paradigms. Behav Processes. 2018 Jul; 152:47-53.